Chronic myeloid leukaemia (CML) presenting in B-lymphoblastic crisis: a diagnostic challenge.
Ke XuElisabeth NachevaPublished in: Journal of hematopathology (2023)
We report the case of a 75-year-old female presented with lethargy, Hb 93 g/L, WBC 64 x 10 9 /L, platelet 110 x 10 9 /L. Blood film showed blasts, myelocytes, metamyelocytes, neutrophils. Quantitative PCR detected p210 BCR::ABL1 transcript in sorted CD19+ cells, and sorted CD19- cells. Bone marrow smear was packed with blasts. Flow cytometry and bone marrow histology revealed B-lymphoblasts. The patient was diagnosed with CML Blymphoblastic crisis. CML presenting in B-lymphoblastic crisis could resemble features of de novo Ph+ B-ALL, which makes the diagnosis challenging. These patients have inferior outcomes; therefore, it is important to distinguishing CML B -lymphoblastic crisis from de novo Ph+ B-ALL. Positive BCR::ABL1 in both CD19+ and CD19- sorted cell populations support the diagnosis of CML B-lymphoblastic crisis in this case.
Keyphrases
- chronic myeloid leukemia
- bone marrow
- public health
- induced apoptosis
- tyrosine kinase
- flow cytometry
- case report
- end stage renal disease
- single cell
- mesenchymal stem cells
- cell cycle arrest
- nk cells
- acute lymphoblastic leukemia
- newly diagnosed
- chronic kidney disease
- stem cells
- rna seq
- dendritic cells
- endoplasmic reticulum stress
- oxidative stress
- acute myeloid leukemia
- prognostic factors
- adipose tissue
- signaling pathway
- cell proliferation
- high resolution
- room temperature
- insulin resistance
- gold nanoparticles
- mycobacterium tuberculosis